Hi Bloky, once the meta data/analysis drops hopefully some time soon, how long do you anticipate it will take before it is included in the national guidelines (are we talking months or years)? Assume the meta includes the use of BIS for a whole range of applications (lymphoema as well as heart failure etc)?
Sorry if these have been explained before.
- Forums
- ASX - By Stock
- IPD
- General
General, page-515
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.6¢ |
Change
-0.002(3.45%) |
Mkt cap ! $113.3M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.5¢ | $62.96K | 1.124M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 299093 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 13651 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 299093 | 0.055 |
2 | 350000 | 0.054 |
1 | 100000 | 0.052 |
1 | 500000 | 0.051 |
5 | 190000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 13651 | 1 |
0.057 | 228450 | 1 |
0.058 | 29118 | 2 |
0.059 | 100000 | 1 |
0.060 | 304887 | 4 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online